Market Overview
The global induced pluripotent stem cell (iPSC) market was valued at USD 1.83 billion in 2024 and is projected to register a CAGR of 10.00% from 2025 to 2034.
Induced pluripotent stem cells are a breakthrough in biomedical research, providing an ethical and versatile alternative to embryonic stem cells. iPSCs enable scientists to generate patient-specific cell lines for disease...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek